Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells
- PMID: 18700925
- DOI: 10.1111/j.1442-9071.2008.01771.x
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells
Abstract
Purpose: To compare the effect on corneal endothelial cells among intracameral moxifloxacin, levofloxacin and cefazoline in rabbits.
Methods: Thirty-six eyes from eighteen rabbits were divided into four groups. The control solution (balanced salt solution), cefazolin 1000 microg/0.1 mL, levofloxain 500 microg/0.1 mL or moxifloxacin 500 microg/0.1 mL was injected into the anterior chamber of the rabbit eye. The central corneal thickness was assessed before the injection of intracameral antibiotics. Endothelial toxicity was evaluated according to the central corneal thickness, specular microscopy, scanning electron microscopy and transmission electron microscopy 1 day after injection.
Results: Before the injection, the central corneal thickness was not different among four groups. After injection, there was no significant difference of the corneal thickness and endothelial cell count between the control and study groups. The central corneal thickness after injection of antibiotics did not significantly change when compared with control. Scanning electron microscopy showed normal hexagonality. Normal architecture of the endothelial cells was noted in transmission electron microscopy in all four groups.
Conclusions: Intracameral injection of antibiotics (cefazolin 1000 microg/0.1 mL, levofloxain 500 microg/0.1 mL, moxifloxacin 500 microg/0.1 mL) did not show significant toxicity on the endothelial cells compared with the control group. Intracameral injection of one of these antibiotics appears to be safe for surgical prophylaxis.
Similar articles
-
Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.J Ocul Pharmacol Ther. 2009 Oct;25(5):425-31. doi: 10.1089/jop.2009.0010. J Ocul Pharmacol Ther. 2009. PMID: 19857104
-
Evaluation of intracameral injection of ranibizumab and bevacizumab on the corneal endothelium by scanning electron microscopy.J Ocul Pharmacol Ther. 2015 Mar;31(2):100-5. doi: 10.1089/jop.2014.0005. Epub 2015 Jan 9. J Ocul Pharmacol Ther. 2015. PMID: 25574702
-
Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.Jpn J Ophthalmol. 2010 Sep;54(5):481-5. doi: 10.1007/s10384-010-0838-5. Epub 2010 Nov 5. Jpn J Ophthalmol. 2010. PMID: 21052913
-
Safety of moxifloxacin as shown in animal and in vitro studies.Surv Ophthalmol. 2005 Nov;50 Suppl 1:S46-54. doi: 10.1016/j.survophthal.2005.05.003. Surv Ophthalmol. 2005. PMID: 16257310 Review.
-
Ocular toxicity of fluoroquinolones.Clin Exp Ophthalmol. 2007 Aug;35(6):566-77. doi: 10.1111/j.1442-9071.2007.01552.x. Clin Exp Ophthalmol. 2007. PMID: 17760640 Review.
Cited by
-
Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens.Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):81-7. doi: 10.1007/s00417-012-2098-1. Epub 2012 Jul 3. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 22752223
-
Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime.Clin Ophthalmol. 2015 Mar 17;9:493-7. doi: 10.2147/OPTH.S74249. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25834384 Free PMC article.
-
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.Br J Ophthalmol. 2018 Sep;102(9):1268-1276. doi: 10.1136/bjophthalmol-2017-311051. Epub 2018 Jan 11. Br J Ophthalmol. 2018. PMID: 29326317 Free PMC article.
-
Effect of intracameral injection of fibrin tissue sealant on the rabbit anterior segment.Mol Vis. 2010 Jun 12;16:1087-97. Mol Vis. 2010. PMID: 20596250 Free PMC article.
-
Injection volume and intracameral moxifloxacin dose.J Cataract Refract Surg. 2019 Oct;45(10):1498-1502. doi: 10.1016/j.jcrs.2019.04.020. Epub 2019 Aug 20. J Cataract Refract Surg. 2019. PMID: 31444079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical